Enzo Biochem, Inc.

Historical 13F Holders

Symbol
ENZB
CUSIP
294100102
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 294100102 since 12/18/2024, newest first.

Filer % of Class Filed
Beryl Capital Management LLC 13G/A Amendment 1
0% 11/14/2025
Event 9/30/2025
Radoff Bradley Louis 13D/A Amendment 6
0% 8/22/2025
Event 8/20/2025
Beryl Capital Management LLC 13G
9.7% 7/1/2025
Event 6/24/2025
Battery Ventures XIV, L.P. 13D
21.8% 6/30/2025
Event 6/23/2025
Radoff Bradley Louis 13D/A Amendment 5
9.2% 6/25/2025
Event 6/23/2025
Harbert Discovery Fund, LP 13D/A Amendment 15
9.9% 6/25/2025
Event 6/23/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 7 2.95 M $2.00 M
2025 Q1 42 13.4 M $4.96 M
2024 Q4 46 13.6 M $9.71 M
2024 Q3 46 12.7 M $14.2 M
2024 Q2 43 12.5 M $13.6 M
2024 Q1 45 14.0 M $17.7 M
2023 Q4 50 16.4 M $22.8 M
2023 Q3 43 16.5 M $23.1 M
2023 Q2 51 18.8 M $34.7 M
2023 Q1 57 19.8 M $61.7 M
2022 Q4 58 19.0 M $27.1 M
2022 Q3 54 20.5 M $45.6 M
2022 Q2 57 21.1 M $43.8 M
2022 Q1 54 21.4 M $62.0 M
2021 Q4 66 21.5 M $69.1 M
2021 Q3 72 23.4 M $82.9 M
2021 Q2 77 24.2 M $76.6 M
2021 Q1 88 27.5 M $94.6 M
2020 Q4 94 31.1 M $78.3 M
2020 Q3 88 28.9 M $61.1 M
2020 Q2 89 28.6 M $64.1 M
2020 Q1 81 28.9 M $73.0 M
2019 Q4 83 32.7 M $86.1 M
2019 Q3 90 32.8 M $118 M
2019 Q2 98 32.6 M $110 M
2019 Q1 87 36.7 M $100 M
2018 Q4 93 32.2 M $89.6 M
2018 Q3 106 32.5 M $134 M
2018 Q2 98 32.3 M $167 M
2018 Q1 110 31.9 M $175 M
2017 Q4 117 30.9 M $252 M
2017 Q3 120 29.9 M $313 M
2017 Q2 123 29.2 M $322 M
2017 Q1 111 28.4 M $237 M
2016 Q4 110 27.2 M $189 M
2016 Q3 112 23.8 M $121 M
2016 Q2 105 24.3 M $145 M
2016 Q1 100 22.1 M $101 M
2015 Q4 92 21.9 M $98.6 M
2015 Q3 83 21.1 M $66.9 M
2015 Q2 86 21.1 M $63.9 M
2015 Q1 91 22.2 M $65.4 M
2014 Q4 89 21.4 M $94.9 M
2014 Q3 95 19.8 M $102 M
2014 Q2 90 17.4 M $91.3 M
2014 Q1 66 13.3 M $55.3 M